CA9 and neoplasm: Since hypoxia and acidosis strongly influence anti-tumor treatment efficacy, targeting hypoxic/acidic TME through CAIX protein can enhance the efficiency of conventional therapies and improve the infiltration of immunocompetent cells or overcome immunotherapy resistance.